As male infertility increases, interest in follicle-stimulating hormone preparations is increasing. So far, women's infertility treatment has been more active than male infertility treatment. 93.4%of the cost of infertility, which was carried out by 2021, was used for female infertility patients, and only 6.6%were used for male infertility patients. Infertility can occur in both men and women due to deficiency of sperm formation due to male sperm, mobility, and low pre -stimulating hormonal glands, or ovarian function of women, closure of fallopian tubes, and endometriosis. According to the Social Society of Society of Propaganda (SRS), the cause of infertility is about 40% of male factors.

Looking at t